4.3 Article

Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Hematology

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

Litao Zhang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients

Jean-Francois Llitjos et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Critical Care Medicine

Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019

Eugene Yuriditsky et al.

CRITICAL CARE MEDICINE (2020)

Article Critical Care Medicine

D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study

Yumeng Yao et al.

JOURNAL OF INTENSIVE CARE (2020)

Article Medicine, General & Internal

D-dimer testing to determine the duration of anticoagulation therapy

Gualtiero Palareti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)